The Roadmap to Orthopreneurship

Want to learn more about the OrthoLazer franchise opportunity? Watch our latest video to learn how we provide you with a GPS guided road map to success with an onboarding process unparalleled in the industry.

By partnering with OrthoLazer you can provide a much needed service to your community by offering an opioid alternative to acute and chronic pain.

Come join our team. Make a difference in your community.

Conditions Treated

OrthoLazer Centers offer a new approach to the treatment of acute and chronic conditions by using a proprietary and patented laser technology to reduce the pain and inflammation associated with a variety of chronic and acute conditions. This includes tough-to-treat issues like IT band tendinitis, tennis elbow, calcific tendinitis, meniscal tears, and plantar fasciitis.

Exclusive Technology

The exclusive technology used in OrthoLazer Centers is the MLS M8 Robotic Laser Therapy – the most advanced therapy laser in the market today. FDA-cleared to treat pain and inflammation, the MLS M8 Robotic Laser technology is non-invasive, fully automated, and completely safe. It works by emitting specific wavelengths of light to treat painful and debilitating conditions. Light energy enters the damaged cells and stimulates intracellular activity, reducing pain in the treated area, and speeding recovery time. It treats the pain and inflammation associated with many common orthopedic conditions including back pain, rotator cuff tears, tennis elbow, sciatica, arthritis, carpal tunnel syndrome, ankle tendinitis, and more.

Hear what our Franchise Owners have to say

Sean Kelly, DO, MPH, explains how the OrthoLazer turnkey “Franchise in a Box” process delivers an entire team committed to franchise success, which leads to better patient outcomes, a new line of revenue, and a new found appreciation from your community for providing them access.

Robert Patz , M.D., and former president of the Massachusetts Orthopaedic Association, along with his partners, is bringing non-invasive, non-opioid pain relief to the Massachusetts area. Hear Dr. Patz’s thoughts on the ability to serve even more patients more efficiently with OrthoLazer Area Development Agreements.

CDC includes laser therapy in proposed guidelines for opioid use.

The Centers for Disease Control (CDC) is updating its guidelines for opioid use (last updated in 2016). We are thrilled to report the proposed guidelines mention the benefit of low-level laser therapy (LLLT) as a potential non-pharmacologic treatment option for multiple pain scenarios.

Frequently Asked Questions

How does MLS M8 Robotic Laser Therapy work?

Laser energy produces changes in oxidation/reduction status of the mitochondria which lead to dramatic increases in ATP synthesis. Activation of the sodium/potassium pump alters the cell membrane permeability to calcium. Laser therapy has been shown to effect cellular activity in the following ways: stimulate cell growth, increase cell metabolism, improve cell regeneration, produce an anti-inflammatory response, produce an edema reduction, reduce fibrous tissue formation, stimulate nerve function, reduce the production of Substance P, and stimulate long-term production of nitric oxide.

Is the MLS M8 Robotic Laser scientifically validated?

The patented MLS M8 Robotic Laser was developed as a result of nearly three decades of scientific research that studied the biological and therapeutic effects of different emission components and methods. The Departments of Biology at both the University of Turin (Italy) and the University of Padova (Brazil), as well as the Department of Anatomy and the Orthopedic Clinic at the University of Padova, have studied and verified the unique effectiveness of MLS M8 Robotic Laser Therapy. There have been more than 2,500 published studies worldwide involving low-level laser therapy, with approximately 120 double-blind studies published.

What are the patient considerations?

The MLS M8 Robotic Therapy Laser is free from any known side effects and has few contraindications. It is, therefore, safe to use for the majority of patients suffering from acute and chronic orthopedic conditions, as well as patients seeking to recover from surgery more quickly. Acute patients typically require 6 treatments over 2-3 weeks. Chronic patients are usually treated 8-12 times over 3-4 weeks. Treatment times range from 4-10 minutes, depending on the condition being treated.

Who can operate the MLS M8 Robotic Laser?

Regulations vary by state and should be closely examined by potential franchisees, however, the majority of states require only a properly trained medical assistant to operate the laser.

Franchising

OrthoLazer is an exclusive opportunity for select orthopedic surgeons and their colleagues to offer their patients and their communities an effective, opioid free, alternative pain management option. We know the constraints orthopedic surgeons have on their time, and that the thought of opening a new franchise business sounds daunting. At OrthoLazer Centers, our Onboarding Roadmap and Implementation Team eliminate all the guesswork – and much of the leg work – involved with opening your OrthoLazer Orthopedic Laser Center. We assist our franchisee partners with real estate site selection, lease negotiation, contractor management, facility design, staff recruiting and training, and on-going support to ensure your success. The OrthoLazer Centers’ business systems and software streamline operations to maximize efficiencies and minimize staffing requirements.